Cumberland Pharmaceuticals CPIX Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's lessee operating lease liability undiscounted excess amount?
- Cumberland Pharmaceuticals (CPIX) reported lessee operating lease liability undiscounted excess amount of $2.38M in Q1 2026.
- How has Cumberland Pharmaceuticals's lessee operating lease liability undiscounted excess amount changed year-over-year?
- Cumberland Pharmaceuticals's lessee operating lease liability undiscounted excess amount decreased by 16.5% year-over-year, from $2.85M to $2.38M.